SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022827
Filing Date
2020-05-07
Accepted
2020-05-07 16:05:37
Documents
78
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20200331.htm   iXBRL 10-Q 2278171
2 EX-10.1 flxn-ex101_41.htm EX-10.1 52209
3 EX-10.2 flxn-ex102_60.htm EX-10.2 15692
4 EX-31.1 flxn-ex311_7.htm EX-31.1 10130
5 EX-31.2 flxn-ex312_8.htm EX-31.2 10245
6 EX-32.1 flxn-ex321_6.htm EX-32.1 9136
7 GRAPHIC ga1ddbnv5uov000001.jpg GRAPHIC 109109
  Complete submission text file 0001564590-20-022827.txt   9152760

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200331.xsd EX-101.SCH 59029
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20200331_cal.xml EX-101.CAL 56550
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20200331_def.xml EX-101.DEF 186551
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200331_lab.xml EX-101.LAB 479394
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200331_pre.xml EX-101.PRE 355904
14 EXTRACTED XBRL INSTANCE DOCUMENT flxn-10q_20200331_htm.xml XML 1777732
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 20856279
SIC: 2834 Pharmaceutical Preparations